Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 27,637 shares at $0.14 ($3K) on 2016-08-25, disclosed to the SEC on 2016-08-25.
Seasonal purchase ($3k) by CEO, 10% Owner — this insider has traded LXRP in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 3,000 | $390 | 11.2% |
| 2 | $0.12 | 14,637 | $2K | 50.2% |
| 3 | $0.13 | 5,000 | $650 | 18.6% |
| 4 | $0.14 | 5,000 | $700 | 20.0% |
| Total | $0.13 avg | 27,637 | $3K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |